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Context: Artificial intelligence (AI) could be a key driver in different healthcare dossiers, ranging 
from preventive to diagnostic and treatment purposes. The establishment of the Artificial 
Intelligence High-Level Expert Group in the European Commission, as well as their White Paper, 
show first attempts of creating policies in the domain of artificial intelligence in the EU. Despite 
these policy approaches, there is a need for a coherent regulatory framework that enables the 
efficient use of AI in the field of health. The aim of this policy brief is to evaluate current legislative 
gaps in terms of the introduction of AI in healthcare, focusing on the domains of Data Protection, 
Liability & Transparency, as well as Robustness & Accuracy. 
Policy Options: This policy brief identified a high degree of eHealth infrastructure fragmentation 
on member state level and limited action towards a structured and coherent framework for AI in 
healthcare, under the domains of Data Protection, Liability & Transparency, and Robustness & 
Accuracy.  
Recommendations: A unified approach at EU-level, based on proposed recommendations and 
merged into the form of a Directive, is advised. The development of the Health-AI-Directive will 
bring progress and improvement to legal certainty in the European AI-landscape. The introduction 
of the Health-AI-Directive is recommended to ensure trust and excellence in the use of AI in 
healthcare. 
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Introduction: Pointing Artificial 
Intelligence in the right direction  
Artificial Intelligence (AI) is frequently 
described as one of the promising 
technologies that could guide crucial societal 
and technological change in the upcoming 
years (1). In the field of public health, AI 
could be a key driver in different domains, 
ranging from preventive to diagnostic 
purposes. Especially, the implementation of 
medical imaging practices through AI-
imaging is likely to revolutionise public 
health practices (2). In the European 
Commission’s (EC) work programme for 
2021, the European Union’s (EU) “fit for the 
digital age” will be attained through the 
creation of legislative developments of 
safety, liability, fundamental rights, and data 
safety of AI (3). This is particularly 
important, given the fact that the EU lacks a 
legal framework on the use of AI as there is 
no legal basis available that regulates the use 
of AI in healthcare. With respect to the 
current amendments in different healthcare 
dossiers, including the expected amendments 
of the Medical Devices Regulation (4), the 
creation of a stringent legislative 
environment of AI in public health is evident. 
Already in 2018, the EC acknowledged the 
need for policy action on AI, and established 
the High-Level Expert Group on Artificial 
Intelligence (AI-HLEG) (5). As a 
consequence, the White Paper “On Artificial 
Intelligence - A European approach to 
excellence and trust” was published (6) and 
opened to consultations with relevant 
stakeholders including civil society, industry, 
and academics from 19 February to 14 June 
2020. Additionally, the EC issued a 
Communication on Building Trust in Human 
Centred Artificial Intelligence (7) and thus 
defined seven characteristics of trustworthy 
AI, namely (I) human agency and oversight, 
(II) technical robustness and safety, (III) 
privacy and data governance, (IV) 
transparency, (V) diversity, non-
discrimination and fairness, (VI) societal and 
environmental well-being as well as (VII) 
accountability. Trust and excellence in AI are 
key requirements for AI-applications in the 
medical field, since sensitive data is 
processed. Against this background, the use 
of AI in healthcare is categorised as high-risk 
AI-applications.  
Despite these policy approaches, the EU 
currently lacks a coherent legally binding 
regulatory framework that would enable the 
efficient use of AI in the field of healthcare. 
Specifically, the perspectives on data 
protection, liability and transparency as well 
as robustness and accuracy should be 
addressed in such a coherent framework. As 
such, the following policy brief aims to 
identify and evaluate current gaps and needs 
in the respective regulatory framework. The 
guiding question and corresponding sub-
questions are therefore: 
Q: Which regulatory legislations are 
necessary for enabling an adequate use of AI 
in healthcare?  
SQ (1): Which existing policies 
address the domains “data 
protection”, “liability & 
transparency”, and “robustness & 
accuracy” for healthcare-AI? 
SQ (2): What are the current gaps in 
legal regulations regarding AI in 
healthcare? 
The overarching vision is to improve patient-
centred healthcare and prevention for all 
European citizens by ensuring faster, more 
effective, and more efficient use of AI in 
healthcare. As such, this policy brief proves 
its relevance in presenting policy 
recommendations on the creation of a legal 
framework for AI-applications in the field of 
healthcare to the EC’s AI-HLEG and other 
relevant stakeholders. 
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Context: Identification of Gaps in Policies 
and Regulations 
This report assessed current gaps and 
limitations in policies and regulations, based 
on six requirements highlighted in the ‘White 
Paper on Artificial Intelligence’ (6), 
established by the EC. The White Paper 
outlines the necessity of elaborating on such 
topics towards further development in future 
regulatory frameworks in AI. These 
requirements include training data, keeping 
of records and data, information provision, 
human oversight, as well as robustness and 
accuracy. 
A literature search regarding policies in each 
of the six requirements was conducted to 
identify the current situation. The framework 
was further delineated into three overarching 
domains: data protection, liability & 
transparency, and robustness & accuracy. 
The resulting search yielded current policies 
and frameworks in use. Findings were 
established and assembled under ‘solutions’, 
which can be found in Table 1. Current gaps 
in each domain and requirements are 
addressed, and framework recommendations 





Infobox 1 – Glimpse of the possibilities: AI in healthcare  
Nowadays, AI is getting more and more presence in healthcare. For example, in ophthalmology, 
the widespread availability of optical coherence tomography (OCT) and a lack of expert 
interpreting results produced by OCT poses a problem. For such medical image analysis and 
referral, AI presents a potential solution. If Deep Learning (DL) combined with the results the 
OCT produces promising outcomes. The AI has an accuracy of 94,5% when identify the type 
of eye disease (8). 
 
In mammography, AI is also on the rise. Mammography’s of 60,886 patients diagnosed with 
breast cancer were used to train a DL model. After this model was introduced, it detected 
women at high risk of breast cancer. It put 31% of all patients in the top risk category for 
potential breast cancer (9). 
 
Figure 1: Infobox 1 - Glimpse of the possibilities: AI in healthcare 
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Table 1:   Current Policies, Frameworks, and Current Gaps Based on Domains 
*- citations refer to the General Data Protection Regulation (17), Declaration on Ethics and Data Protection in AI (20), Charter of Fundamental Rights of the European Union (21), and Cybersecurity Act (34)
Domains Solutions Current Policy Instruments & Frameworks* Current Gaps/Needs 
Data protection Training Data:  
- Assurance that use of products and services 
are safe  
- Tackle discrimination 
- Protection of personal and private data 
GDPR:  
Art. 5 (1)(f) 
Art. 6 (1)(d&f) 

















Rights of the 
EU:  
Art. 8 (2)  
Art. 21 
No specific regulation for 
training data in healthcare 
with AI in general data 
protection guidelines, and for 
medical devices. 
Keeping of Records and Data:  
- Records of dataset development to use for 
training data and testing  
- Methodologies for programming, training, 
building, testing & validating AI 
GDPR:  
Art. 5 (1)(e) 
Art. 30 
No AI-specific verifiability 
and compliance measures.  
No data retention framework; 
policies only at national level.  
Liability & 
Transparency 
Information Provision:  
- Information about AI’s capabilities and 
limitations 
- Inform citizens, when they interact with an 
AI system 
GDPR:  
Art. 13 (2)(f)  
Need for clearer transparency 
guidelines about the 
functionality of AI-systems.  
Human Oversight:  
- Output reviewed and validated by a human  
- Ensure human intervention after AI output  
- Impose operational constraints on AI system 
GDPR:  
Art. 22 
Governance mechanism of 
how to implement the 
safeguards is not defined. 
Robustness & 
Accuracy 
- Robust and accurate during all life cycles 
phases 
- Reproducible outcomes 
- Adequately able to deal with errors 
inconsistencies during all life cycle phases 
- Resilient against cyberattacks 
Cybersecurity Act GDPR European cybersecurity 
certificate.  
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Policy Options: Identification of needs and 
recommendations for AI-requirements 
AI poses great opportunities for healthcare. 
To lead this development in a direction that 
mitigates potential risks, regulations are 
required. In the following sections the current 
gaps are discussed, followed by 
recommendations to address these gaps. 
 
Data Protection  
This domain is differentiated into the parts 
“Training Data” and “Keeping of Records 
and Data”. These parts go into depth on how 
AI training data should be regulated and how 
it should be stored. 
 
Training Data  
Training data in AI is the personal data that is 
used to direct the programme to recognise 
patterns and use the technology (e.g., neural 
networks) accurately and accordingly (13-
15). Training data sets the basis for the 
functioning of the whole AI-process and -
system. Therefore, sufficient training data is 
fundamental for a sufficient AI-system (13). 
Several challenges regarding training data 
arise that have not yet been sufficiently 
addressed in mandatory legal requirements 
(6). Assurance of safety of the products and 
services used by the AI-system, according to 
the standards of the EU, is necessary (6). A 
regulation for safety of medical devices can 
be found in Art. 5(2) of the Regulation (EU) 
2017/745 on medical devices (16). The 
General Data Protection Regulation (GDPR) 
regulates the general security of processing 
personal data in Art. 32 (17). Additionally, 
measures should be addressed which ensure 
that the use of AI does not lead to 
discrimination (6). The training dataset is 
often smaller and differs from the targeted 
population (18). For this reason, a regulation 
to detect, avoid, and counteract discrepancies 
between the target population and the 
training data is crucial to avoid bias in the 
output of AI in healthcare (19). Avoidance of 
bias in AI is mentioned in the Declaration on 
Ethics and Data Protection in AI (20).  
Universal laws protecting people against 
discrimination can be found in Art. 21 of the 
Charter of Fundamental Rights of the EU 
(CFR) (21) and in Art. 9(1) of the GDPR 
(17). Lastly, regulations for adequate 
protection of personal data, used in the 
context of AI in healthcare, is needed (6). 
Regulations for protection of personal data 
can be found in Art. 8(2) of the CFR, as well 
as in the Art. 5(1)(f), Art. 6(1)(d+f), and Art. 
35 of the GDPR (17). Additionally, the 
Declaration on Ethics and Data Protection in 
AI mentions the need for protection of 
personal data during the development of AI 
(20).







Infobox 2 – Biased AI 
AI that contains existing prejudices of the developers, 
resulting in discrimination or lack of fairness in 
automated decision-making. Biases in AI mostly occur 
through unrepresentative or incomplete training data, 
especially the underrepresentation of minority groups 
resulting in disadvantages (11, 12). Groups mostly 
affected by AI biases are people of black race, people 
from the Asian continent, woman and disabled (10, 12). 
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Even though the stated aspects are generally 
regulated in several legislative documents, 
there is no specific regulation addressing AI-
training data in healthcare. Noted, general 
regulations apply for AI-training data in 
healthcare. Nevertheless, the specificity for a 
sufficient execution of the stated solutions in 
healthcare with AI in regard to training data 
is missing. Therefore, a separate legislative 
regulation addressing the processing of AI-
training data in the context of healthcare is 
advisable.  
Keeping of Records and Data  
Under the data protection domain, there is a 
need for verification in compliance within 
algorithm development and programming. 
This requires record- and data-keeping within 
entities that intend to utilise AI-technology at 
multiple levels, from design to development 
to implementation, and continuous 
execution. Art. 30 of the GDPR requires 
maintenance of records used in data-
processing to determine each activity that 
involves the use of personal data (17). AI-
specific measures in record-keeping 
compliance in healthcare are limited, though. 
Furthermore, one of the principles in Art. 
5(1)(e) of the GDPR states that data, under 
legal obligations, is to be kept for the shortest 
time that is applicable (17). Also, data 
generated in AI-algorithms merges to form 
an output, making it difficult to find a 
solution to track or delete inputted data. At 
EU-level, no data retention policy appears to 
exist since the removal of Directive 
2006/24/EC (22). National level policies 
have been implemented instead (23).Current 
methods to respond to this need revolves 
around ‘Verifiable AI’. Verifiable AI aims to 
certify each step in the process of AI-
development for auditing, prior to 
deployment (24). This would provide 
mechanisms whereby entities would exercise 
better practices in retaining data and datasets 
for the purpose of traceability and to promote 
compliance. To further propagate a sound 
regulatory framework and strategy towards 
record- and data-keeping, audited trails are 
valuable for accountability (25). Ai4EU, a 
consortium sponsored by the EC, specifies a 
toolbox called ‘VERIFAI’ with the aim to 
verify steps in design and run time (26). 
Therefore, an EU-wide policy in AI-specific 
data retention is recommended, due to the 
novel risk this type of data poses. This would 
also have to comply with the CFR.  
 
Liability & Transparency 
Under the data protection domain, there is a 
This domain is divided into “information 
provision” and “human oversight”. This part 
is an elaboration on how information of the 
functioning of AI should be regulated. 
Afterwards, the supervision of AI-systems 
will be discussed. 
 
Information Provision 
In terms of providing information on the 
development and use of AI in healthcare, a 
lack of transparency can be described as the 
main issue. To achieve transparency, it is 
important to deal with the so-called "black 
box" of an AI-application. This means 
understanding the aspects of an AI that 
influence the decision-making process. 
Therefore, it is important to strive for 
transparency, not only regarding the 
algorithms themselves, but also regarding the 
data and the automated decision making 
(ADM) processes, as well as transparency 
within the conceptual business model. The 
AI-HLEG identified transparency as a key 
requirement for AI-applications in healthcare 
in order to count as trustworthy (7). In their 
White Paper, a lack of transparency regarding 
the current legislation was described as a 
major problem (6). Moreover, the call for 
transparency and accountability is not only 
present in the EU, but also in the USA (27). 
There are two necessary requirements when 
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providing information to achieve 
transparency, which are 1) clear information 
regarding the AI-system’s capabilities and 
limitations and 2) clear information to 
citizens on the fact that they are interacting 
with an AI-system and not with a human. The 
latter is covered to some extent in Art. 
13(2)(f) of the GDPR, where it is stated that 
“controllers must, at the time when the 
personal data are obtained, provide the data 
subjects with further information necessary 
to ensure fair and transparent processing 
about the existence of automated decision-
making and certain additional information” 
(17). To close the regulatory gap of clear 
transparency guidelines on the functionality 
of an AI-system, the introduction of 
mandatory self-identification of these 
systems is recommended. This particularly 
applies to the purpose and conditions under 
which they are planned to function and their 
estimated level of accuracy (28). 
Additionally, detailed documentation of the 
decisions made by the AI-systems and the 
entire process (including business model 
transparency) is required (7). The 
information that is provided needs to be 
objective, concise, and easily understandable. 
In order to provide appropriate information 
about the application of AI-systems, policy 
makers need to consider the circumstances 
within their particular context of decision-
making. 
Human Oversight 
Within the domain of liability and 
transparency, the aspect of human oversight 
of AI’s decision making plays a crucial role. 
AI presents an undeniable potential to assist 
health professionnels (e.g radiologists) 
performance (35) in medical diagnostics. 
However, human oversight ensures that AI 
does not undermine human autonomy, whilst 
defining the liability of decisions made. 
Human oversight is determined by four main 
characteristics: (I) output reviewed and 
validated by a human, (II) ensuring human 
intervention after AI-output, (III) AI-
monitoring and the ability to intervene, as 
well as (IV) imposing operational constraints 
on AI-systems (29). Against this background, 
Art. 22 of the GDPR defines the legal basis 
for automated, individual decision making 
and aims to implement safeguarding 
measures to the data subject’s interests. 
According to Art. 22 of the GDPR, 
autonomous decisions must always be 
contested by humans (17). Nevertheless, a 
gap in the current policy framework shows no 
information on how to practically implement 
the mechanism of human oversight.  This is 
especially important to address in the sense 
of AI's use in the field of (public) health. 
Hereby, three governance mechanisms are 
available. Firstly, human-in-the-loop (HITL), 
which refers to the introduction of human 
intervention in every step of the decision-
making process. Secondly, human-on-the-
loop (HOTL), which considers the capability 
of human oversight within the design-cycle 
as well as the monitoring of the AI’s 
decision-making. Thirdly, the human-in-
command (HIC) approach that allows human 
oversight of the overall activity of the AI-
system, taking into account the economic, 
societal, legal, as well as ethical perspective 
(6).  
With respect to the use of AI in the health 
sector, the mechanism of human-in-
command (HIC) can be identified as the most 
desirable one. This governance mechanism 
covers the cluster of public health 
holistically, considering the economic, 
societal, legal, and ethical points of view. In 
addition to that, the approach is favoured by 
high EU civil servants, such as 
Commissioner for Innovation, Research, 
Culture, Education, and Youth, Mariya 
Gabriel (30).  Nevertheless, effective use of 
this governance approach entails certain 
implications, such as sufficiently trained 
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personnel capacities and corresponding 
financial capacities.  
Robustness & Accuracy 
In order to be trustworthy, AI-systems, 
particularly high-risk AI-systems, must be 
technically robust and accurate. Some AI-
requirements need to be ensured to prevent 
problems according to the EC (6). AI-
systems need to be (I) robust and accurate 
during all life cycle phases, (II) have 
reproducible outcomes, (III) be able to 
adequately deal with errors or inconsistencies 
during all life cycle phases, for example 
through control algorithms, and (IV) be 
resilient against cyberattacks (6). In a report 
by Hamon, Junklewitz & Sanchez (31), the 
reliability of outcomes, data-protection, and 
transparency of AI-models to prevent issues 
is stressed. Accuracy and transparency have 
a difficult interdependence within AI-
applications. It is often the case that the more 
accurate a model is, the lower the 
transparency. This raises the question on 
whether the ability to describe how data is 
obtained may be less important than the 
ability to generate those results and validate 
their accuracy empirically (32).Currently, 
efforts are being made to provide policies on 
cybersecurity. This has implications for the 
robustness of AI-applications. The 
Cybersecurity Act, adopted in 2019, gives the 
EU a mandate on cybersecurity as the 
European Union Agency for Cybersecurity is 
making European cybersecurity certification 
schemes, which all the Member States have 
to comply with once implemented. Hamon et 
al. (31), propose designing a framework, 
using the GDPR, to make an evaluation that 
assesses the impacts of AI-systems on 
society. They also recommend the 
introduction of systematic methodologies to 
test the robustness of AI-models. Finally, 
sharing identified AI-model vulnerabilities 
and technological solutions to fix them 
among AI-practitioners is stressed. The 
GDPR generally provides meaningful 
indications for data protection in the context 
of AI-applications and could be used as a 
foundation to create a regulatory framework 
for AI in healthcare (33).  
Recommendations: Roadmap for the 
implementation process 
With respect to the identified gaps within the 
regulatory framework, as stated in the 
previous section, the following policy 
recommendations (Table 2) are directed 
towards the AI-HLEG. Hereby, it is 
emphasised that there are overlaps in the 
current framework that are thus mirrored 
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Table 2: Policy Recommendations for each Domain 




To introduce a legislative regulation specifically 
addressing safety, avoidance of bias, and protection of 





To provide legislation for compliance and verifiability 
of AI, particularly audit trails and data tracing, and 






To ensure transparency by introducing a mandatory 
self-identification and documentation of AI-systems in 
healthcare as well as their business models by 
addressing 1) their exact purposes and ways of 
automated decision-making, 2) the conditions under 
which they are planned to function and 3) their 
estimated level of accuracy. 
Human 
Oversight 
To implement the human-in-command governance 
approach to AI applications, this implies to train and 
accumulate personnel capacities able to oversee the AI 
application (background in governance, health, and life 
science as well as digitization and its implications). 
Robustness & Accuracy 
 
To implement and enforce a framework, based on the 
GDPR, that would set rules for AI-cybersecurity across 
the EU e.g. promoting transparency. Within the 
framework, a platform to share knowledge of AI-
vulnerabilities and technological solutions should be 
incorporated. 
Overall Recommendation 
To implement one overall legislative regulation for AI 
in healthcare addressing all three domains of data 
protection, liability and transparency, and robustness 
and accuracy. 
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From recommendation to implementation 
through legislation: A Health-AI-
Directive?  
The need for a framework dealing with AI in 
healthcare has been highlighted in the 
previous sections. The urgency of 
implementing this framework could also be 
shown by pointing out current gaps of AI-
related regulations in the GDPR and other EU 
law, since the gaps within the framework 
allow space for further policy actions. With 
respect to the actual implementation of the 
suggested recommendations, several 
governance perspectives must be taken into 
consideration. This is particularly true given 
the involvement of multi-faceted 
stakeholders and their interests in the field of 
healthcare. Debates are likely to arise, 
questioning the competence of the EU in 
terms of creating legislation in the field of 
healthcare. However, in order to compete 
with and even exceed other global players in 
the realm of AI in healthcare, such as the 
USA and China, the EU needs to act unified 
and develop an accurate AI-framework. 
At the EU-level, a unified approach, guided 
by the AI-HLEG, to transfer the current 
considerations from the White Paper into the 
form of a Directive, is advised. The 
development of this Directive would provide 
a basis for a legal framework, and merge into 
national law of the Member States. 
Additionally, this process would ensure a 
legally binding basis for a unified policy 
approach among the EU Member States 
concerning the use of AI in the field of 
healthcare. 
In practice, this means that political decision-
makers must always incorporate the aspects 
of data protection, accountability and 
transparency, as well as robustness and 
accuracy, into any decision-making-process 
on the use of AI in their specific context. 
Against this background, a Health-AI-
Directive is the most favourable instrument. 
On the one hand it allows the Member States 
a certain degree of flexibility to adapt the 
regulations on the use of AI in line with the 
specific conditions of their national 
healthcare system. On the other hand, a 
common path in the EU can be fostered by 
ensuring compliance with the key objectives 
in the context of AI. Hereby, the contextual 
national frameworks and differing national 
priority setting, as well as the urgency of a 




The development and establishment of the 
Health-AI-Directive as a regulatory EU-wide 
AI-framework, based on the 
recommendations above, constitutes one way 
to bring progress and improvement to legal 
certainty in the AI-landscape of the EU. It 
will counteract the fragmentation of the AI 
infrastructures among the Member States and 
contribute to the objectives of the AI-HLEG 
of “trust, legal certainty and market uptake” 
(6). This will strengthen the EU to pave the 
way for a trustworthy usage of high-quality 
AI in healthcare. 
References 
 
1. EIT Health and McKinsey & 
Company. Transforming healthcare 
with AI. The impact on the 
workforce and organisations.: EIT 
Health, European Union; 2020. 
2. Oren O, Gersh BJ, Bhatt DL. 
Artificial intelligence in medical 
imaging: switching from 
radiographic pathological data to 
clinically meaningful endpoints. The 
Lancet Digital Health. 
2020;2(9):e486-e8. 
3. European Commission. 
Communication from the 
Commission to the European 
 
Bimczok, S. P., Godynyuk, E. A., Pierey, J., Roppel, M. S., & Scholz, M. L. How is excellence and 
trust for using artificial intelligence ensured? Evaluation of its current use in EU healthcare 
(Policy brief). SEEJPH 2021, posted: 18 April 2021. DOI: 10.11576/seejph-4685 
 
P a g e 12 | 14 
Parliament, The Council, The 
European Economic and Social 
Committee and the Committee of the 
Regions. Commission Work 
Programme 2021. A Union of 
vitality in a world of fragility. 2020. 
4.  MedTech Europe. MedTech Europe 
welcomes the amendment of the 
Medical Devices Regulation and 
urges similar action for the IVD 









0and. [Accessed 02 December 2020] 
5. European Commission. 
Communication from the 
Commission to the European 
Parliament, the European Council, 
the Council, the European Economic 
and Social Committee and the 
Committee of the Regions on 
Artificial Intelligence for Europe 
2018. 
6. European Commission. White paper. 
On artificial intelligence – A 
European approach to excellence and 




feb2020_en.pdf [Accessed 23 
November 2020] 
7. European Commission. 
Communication from the 
Commission to the European 
Parliament, The Council, the 
European Economic and Social 
Committee and the Committee of the 
Regions. Building Trust in Human-
Centric Artificial Intelligence. 
COM(2019)168/F12019. 
8. De Fauw J, Ledsam JR, Romera-
Paredes B, Nikolov S, Tomasev N, 
Blackwell S, et al. Clinically 
applicable deep learning for 
diagnosis and referral in retinal 
disease. Nature Medicine. 
2018;24(9):1342-50. 
9. Yala A, Lehman C, Schuster T, 
Portnoi T, Barzilay R. A Deep 
Learning Mammography-based 
Model for Improved Breast Cancer 
Risk Prediction. Radiology. 
2019;292(1):60-6. 
10.  Parikh RB, Teeple S, Navathe AS. 
Addressing Bias in Artificial 
Intelligence in Health Care. JAMA. 
2019;322(24):2377-8. 
11.  Obermeyer Z, Powers B, Vogeli C, 
Mullainathan S. Dissecting racial 
bias in an algorithm used to manage 
the health of populations. Science. 
2019;366(6464):447. 
12. Kuner C, Svantesson DJB, Cate FH, 
Lynskey O, Millard C. Machine 
learning with personal data: is data 
protection law smart enough to meet 
the challenge? International Data 
Privacy Law. 2017;7(1):1-2. 
13. Maes F, Robben D, Vandermeulen 
D, Suetens P. The Role of Medical 
Image Computing and Machine 
Learning in Healthcare. In: 
Ranschaert ER, Morozov S, Algra 
PR, editors. Artificial Intelligence in 
Medical Imaging: Opportunities, 
Applications and Risks. Cham: 
Springer International Publishing; 
2019. p. 9-23. 
14. Schmidt FA. Crowdsourced 
production of AI Training Data: 
How human workers teach self-
driving cars how to see. Working 
Paper Forschungsförderung; 2019 
 
Bimczok, S. P., Godynyuk, E. A., Pierey, J., Roppel, M. S., & Scholz, M. L. How is excellence and 
trust for using artificial intelligence ensured? Evaluation of its current use in EU healthcare 
(Policy brief). SEEJPH 2021, posted: 18 April 2021. DOI: 10.11576/seejph-4685 
 
P a g e 13 | 14 
15. Verma D, Julier S, Cirincione G. 
Federated AI for building AI 
Solutions across Multiple Agencies. 
ArXiv. 2018;abs/1809.10036. 
16. European Parliament. Regulation 
(EU) 2017/745 of the European 
Parliament and of the Council of 5 




2017R0745. [Accessed 23 November 
2020] 
17. European Parliament and Council of 
European Union. Regulation (EU) 
2016/679 of the European Parliament 
and of the Council of 27 April 201 
on the protection of natural persons 
with regard to the processing of 
personal data and on the free 
movement of such data (GDPR) 




[Accessed 27 November 2020] 
18. Oakden-Rayner L, Palmer LJ. 
Artificial Intelligence in Medicine: 
Validation and Study Design. In: 
Ranschaert ER, Morozov S, Algra 
PR, editors. Artificial Intelligence in 
Medical Imaging: Opportunities, 
Applications and Risks. Cham: 
Springer International Publishing; 
2019. p. 83-104. 
19. Harvey H, Heindl A, Khara G, 
Korkinof D, O’Neill M, Yearsley J, 
et al. Deep Learning in Breast 
Cancer Screening. In: Ranschaert 
ER, Morozov S, Algra PR, editors. 
Artificial Intelligence in Medical 
Imaging: Opportunities, Applications 
and Risks. Cham: Springer 
International Publishing; 2019. p. 
187-215. 
20. International Conference of Data 
Protection & Privacy Commissioners 
(ICDPPC). Declaration on Ethics 
and Data Protection in Artificial 




[Accessed 27 November 2020] 
21. Charter of Fundamental Rights of the 
European Union (2000/C 364/01) 
(CFR).  Available from: https://eur-
lex.europa.eu/legal-
content/EN/TXT/?uri=CELEX%3A1
2012P%2FTXT. [Accessed 27 
November 2020] 
22. European Commission. The Court of 
Justice declares the Data Retention 
Directive to be invalid [Press 
release]. 2014. Available 
from:https://ec.europa.eu/commissio
n/presscorner/detail/en/CJE_14_54. 
[Accessed 25 November 2020] 
23. European Commission. Data 





[Accessed 23 November 2020] 
24. Jacques Robin and Florian 
Zimmermann (editors), “A simple 
guide to Verifiable AI”. Published on 
the AI4EU platform: 
https://www.ai4eu.eu/ June 24, 2020. 
25. Brundage M, Avin S, Wang J, 
Belfield H, Krueger G, Hadfield G, 
et al. Toward trustworthy AI 
development: mechanisms for 
supporting verifiable claims. arXiv 
preprint arXiv:200407213. 2020. 
26. Dreossi T, Fremont DJ, Ghosh S, 
Kim E, Ravanbakhsh H, Vazquez-
Chanlatte M, et al., editors. VerifAI: 
A Toolkit for the Formal Design and 
Analysis of Artificial Intelligence-
 
Bimczok, S. P., Godynyuk, E. A., Pierey, J., Roppel, M. S., & Scholz, M. L. How is excellence and 
trust for using artificial intelligence ensured? Evaluation of its current use in EU healthcare 
(Policy brief). SEEJPH 2021, posted: 18 April 2021. DOI: 10.11576/seejph-4685 
 
P a g e 14 | 14 
© 2021 Bimczok, S.P. et al.; This is an Open Access article distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited. 
 
Based Systems; 2019; Cham: 
Springer International Publishing. 
27. Garfinkel S, Matthews J, Shapiro SS, 
Smith JM. Toward algorithmic 
transparency and accountability. 
ACM New York, NY, USA; 2017. 
28. High Level Expert Group on 
Artificial-Intelligence. Policy and 
Investment Recommendations for 
Trustworthy AI. Brussels: European 
Commission; 26 June 2019. 
29. European Commission. 
Requirements of Trustworthy AI 
2020. Available from: 
https://ec.europa.eu/futurium/en/ai-
alliance-consultation/guidelines/1. 
[Accessed 04 December 2020] 
30. Euractiv. Digital Brief: Tech 
Biopower. 2019 Available from: 
https://www.euractiv.com/section/di
gital/news/digital-brief-tech-
biopower/. [Accessed 04 December 
2020] 
31. Hamon R, Junklewitz H, Sanchez I. 
Robustness and explainability of 
artificial intelligence. Publications 
Office of the European Union. 2020. 
32. London AJ. Artificial Intelligence 
and Black-Box Medical Decisions: 
Accuracy versus Explainability. 
Hastings Cent Rep. 2019;49(1):15-
21.  
33. European Parliamentary Research 
Service. The impact of the General 
Data Protection Regulation (GDPR) 
on artificial intelligence 
Luxembourg: Office for Official 
Publications of the European 




[Accessed 23 November 2020] 
34. European Parliament and Council of 
the European Union. Regulation 
(EU) 2019/881 of the European 
Parliament and of the Council of 17 
April 2019 on ENISA (the European 
Union Agency for Cybersecurity) 
and on information and 
communications technology 
cybersecurity certification and 
repealing Regulation (EU) No 
526/2013 (Cybersecurity Act) 2019.  
Available from: https://eur-
lex.europa.eu/eli/reg/2019/881/oj 
[Accessed 04 December 2020] 
35.  Allen B, Jr., Seltzer SE, Langlotz 
CP, Dreyer KP, Summers RM, 
Petrick N, et al. A Road Map for 
Translational Research on Artificial 
Intelligence in Medical Imaging: 
From the 2018 National Institutes of 
Health/RSNA/ACR/The Academy 
Workshop. Journal of the American 
College of Radiology. 
2019;16(9):1179-89. 
36. Challen R, Denny J, Pitt M, Gompels 
L, Edwards T, Tsaneva-Atanasova 
K. Artificial intelligence, bias and 
clinical safety. BMJ Quality &amp; 
Safety. 2019;28(3):231-7.
 
